Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 NOK | +2.42% | -1.40% | -19.08% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Sales 2022 | 120M 11.49M | Sales 2023 | 219M 20.84M | Capitalization | 1.04B 98.72M |
---|---|---|---|---|---|
Net income 2022 | -137M -13.07M | Net income 2023 | -107M -10.2M | EV / Sales 2022 | 11.4 x |
Net Debt 2022 | 71.74M 6.84M | Net Debt 2023 | 257M 24.5M | EV / Sales 2023 | 5.91 x |
P/E ratio 2022 |
-8.89
x | P/E ratio 2023 |
-9.7
x | Employees | 70 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.78% |
1 day | +2.42% | ||
1 week | -1.40% | ||
1 month | +4.43% | ||
3 months | -9.79% | ||
6 months | -22.34% | ||
Current year | -19.08% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.12 | +2.42% | 10,835 |
24-05-30 | 2.07 | -0.96% | 7,746 |
24-05-29 | 2.09 | -0.48% | 14,605 |
24-05-28 | 2.1 | -2.33% | 26,498 |
24-05-27 | 2.15 | -.--% | 4,979 |
Real-time Oslo Bors, May 31, 2024 at 10:45 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.08% | 79.67M | |
-2.00% | 277B | |
-5.38% | 91.92B | |
-4.35% | 42.95B | |
+0.75% | 41.25B | |
+6.11% | 40.01B | |
+5.54% | 38.81B | |
-13.54% | 30.87B | |
-11.43% | 27.21B | |
+7.73% | 24.19B |
- Stock Market
- Equities
- HBC Stock